HRS-9821

N/A

Report date: 2026/05/22 20:01:29
NME

Base Information

Drug NameHRS-9821
Drug Alias NameHRS-9821HRS9821GSK-6582701
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitorsPhosphodieterase 4 inhibitors
TargetsPhosphodiesterase 3Phosphodieterase 4
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangdong Hengrui Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangdong Hengrui Pharmaceutical Co LtdGlaxosmithkline Intellectual Property (No.3) LtdGlaxosmithkline Intellectual Property (No.4) Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A